Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases.
about
Positron Emission Tomography in Breast CancerContemporary approaches for imaging skeletal metastasisNormal SUV values measured from NaF18- PET/CT bone scan studiesImaging findings in 22 cases of Schnitzler syndrome: characteristic para-articular osteosclerosis, and the "hot knees" sign differential diagnosis.Sodium 18F-fluoride PET/CT of bone, joint, and other disorders.Comparison of standardized uptake values measured on F-NaF PET/CT scans using three different tube current intensitiesCurrent and emerging therapies for bone metastatic castration-resistant prostate cancer.18F-NaF Positive Bone Metastases of Non 18F-FDG Avid Mucinous Gastric Cancer.Receiver operating characteristic (ROC) curve for classification of (18)F-NaF uptake on PET/CT.Current approaches and challenges in early detection of breast cancer recurrence.Validation of the Association of RECIST Changes With Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated on SWOG Study S0421.Differentiation of metastatic vs degenerative joint disease using semi-quantitative analysis with (18)F-NaF PET/CT in castrate resistant prostate cancer patients.(68) Ga-PSMA PET/CT for the detection of bone metastases in prostate cancer: a systematic review of the published literature.Advances in prostate-specific membrane antigen PET of prostate cancer.Whole-body [¹⁸F]FDG PET/MRI vs. PET/CT in the assessment of bone lesions in oncological patients: initial results.Is 18F-FDG PET/CT more reliable than 99mTc-MDP planar bone scintigraphy in detecting bone metastasis in nasopharyngeal carcinoma?
P2860
Q26768486-A51DE9B3-17BC-4C8F-B322-C96EB566D165Q26798170-120AEB46-40C8-4C16-B109-4F79DCD9F37AQ34257450-FEF008A6-1735-48A5-99F7-19F89B5D3B44Q34411281-68CD6977-CA40-4D13-8748-924C3006E667Q34642993-7D480286-67C6-4853-ADAE-0041AFD57648Q35195454-A2562C3D-E756-46B6-9612-B46223C31784Q36358303-7E3D63D8-F0B4-48B4-929C-1E7CD24CEC04Q36556529-81F408D8-CE6F-4F9D-A15D-786E1E59C87FQ36628451-F6B0A436-ED92-4BC9-AEE2-6820A0D692ADQ37695256-2D4A3BB4-5FC2-464D-AB41-1B9E4424E259Q38745926-0ABBEC90-9AE1-4EA6-9158-F436AC544A9EQ39607583-6BEF7F79-DDD4-4999-9E06-68DE410861B2Q47693515-7D410EE1-5ED1-46E7-A581-AD88A6D35380Q49713199-F4E80C44-D748-4295-B8B6-7B6DB14B69BCQ53063558-489CC203-5FAE-4492-8CF2-A9F83BAC40FDQ53076138-02AB6C82-E2AF-483C-9625-656A92D131F3
P2860
Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Pilot prospective evaluation o ...... ection of skeletal metastases.
@ast
Pilot prospective evaluation o ...... ection of skeletal metastases.
@en
type
label
Pilot prospective evaluation o ...... ection of skeletal metastases.
@ast
Pilot prospective evaluation o ...... ection of skeletal metastases.
@en
prefLabel
Pilot prospective evaluation o ...... ection of skeletal metastases.
@ast
Pilot prospective evaluation o ...... ection of skeletal metastases.
@en
P2093
P1476
Pilot prospective evaluation o ...... tection of skeletal metastases
@en
P2093
Andrei Iagaru
Erik Mittra
Phillip Young
Robert Herfkens
Sanjiv Sam Gambhir
P304
P356
10.1097/RLU.0B013E3182815F64
P577
2013-07-01T00:00:00Z